SCHEMBL7703244

SCHEMBL7703244

COc1cccc(-c2cc(N)n3nc(-c4ccccc4)nc3c2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.47
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ NFKB1 P19838 2/20 0.47
▸ NFKB2 Q00653 2/20 0.47
▸ RELA Q04206 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ NR1H2 P55055 3/20 0.46
▸ NR1H3 Q13133 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.45
▸ HPGD P15428 3/20 0.45
▸ HTT P42858 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ ADORA2A P29274 4/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ PKM P14618 1/20 0.44
▸ CDK5 Q00535 1/20 0.44
▸ CDK5R1 Q15078 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708784 0.89 SMN1; SMN2 (0.54) DPP4NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL7709143 0.87 RXRA (0.44) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL7483006 0.86 NPC1 (0.53) NPC1RAB9ASMN1; SMN2TDP1TP53
SCHEMBL7486137 0.85 ADORA2A (0.54) ADORA2A
SCHEMBL7708503 0.84 NPC1 (0.53) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL7423524 0.84 ALDH1A1 (0.53) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL7708864 0.83 TDO2 (0.41) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL7487041 0.83 ADORA2A (0.51) NPC1RAB9ASMN1; SMN2TP53ALDH1A1
SCHEMBL7709122 0.83 MAOA (0.47) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL7703022 0.82 NPC1 (0.56) NPC1RAB9ASMN1; SMN2NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 — — US disclosed
Send feedback